IGF2BP3 and hepatocellular carcinoma: In an extensive analysis encompassing 82 datasets from 39 different platforms, which included 3891 HCC and 3389 non-HCC samples, we observed a significant overexpression of IGF2BP3 mRNA in HCC tissues compared to normal liver tissues (SMD = 1.20, 95% CI = 1.05–1.36, Fig. S1).